Aptamer Group

Aptamer Group is the developer of custom affinity tools for the life science industry through its proprietary Optimer® platform.

Optimer® binders are nucleic acid-based affinity ligands that can be used as an antibody alternative to offer novel solutions and improvements to current processes across the therapeutic, diagnostic, bioprocessing and research sectors. Offering rapid development in just weeks, full platform compatibility and tuneable binding kinetics to ensure desired end-use performance, Optimer® binders are enabling scientists to hit new targets and build better assays.